Idera Pharmaceuticals Inc IDRA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 12:26 PM EDT
0.4106quote price arrow down-0.0134 (-3.1604%)
Volume
11,356
52 week range
0.29 - 1.04
Loading...
  • Open0.3947
  • Day High0.4142
  • Day Low0.3939
  • Prev Close0.424
  • 52 Week High1.04
  • 52 Week High Date10/07/21
  • 52 Week Low0.29
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap25.58M
  • Shares Out62.30M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change-27.37

KEY STATS

  • Open0.3947
  • Day High0.4142
  • Day Low0.3939
  • Prev Close0.424
  • 52 Week High1.04
  • 52 Week High Date10/07/21
  • 52 Week Low0.29
  • 52 Week Low Date05/12/22
  • Market Cap25.58M
  • Shares Out62.30M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change-27.37

RATIOS/PROFITABILITY

  • EPS (TTM)-0.39
  • P/E (TTM)-1.04
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-19.487M
  • ROE (TTM)-70.40%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,536.19%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Idera Pharmaceuticals Inc

 

Content From Our Affiliates

Profile

MORE
Idera Pharmaceuticals, Inc. is a biopharmaceutical company that is focused on the clinical development, and commercialization of drug candidates for rare diseases and oncology. The Company is developing tilsotolimod, an investigational Toll-like receptor 9 agonist, for the treatment of advanced solid tumors. Its lead investigational product, tilsotolimod, demonstrated activity in various pre-clinical models and is in clinical development across several oncology indications....
Vincent Milano
Chairman of the Board
John Taylor
Chief Executive Officer, Director
Daniel Salain
Chief Operating Officer
John Kirby CPA
Chief Financial Officer, Senior Vice President
Address
505 Eagleview Boulevard, Suite 212
Exton, PA
19341
United States

Top Peers

SYMBOLLASTCHG%CHG
ITRM
Iterum Therapeutics PLC
1.86-0.05-2.62%
NNVC
NanoViricides Inc
1.61-0.06-3.59%
GRAY
Graybug Vision Inc
0.95-0.0299-3.0513%
NDRA
ENDRA Life Sciences Inc
0.31-0.02-6.0606%
MNPR
Monopar Therapeutics Inc
1.97+0.23+13.22%
ONCS
OncoSec Medical Inc
0.4743+0.0232+5.14%